Oncotelic Therapeutics Inc (OTLC)
0.038
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Oncotelic Therapeutics Shareholders Equity (Quarterly): 11.83M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.83M |
December 31, 2023 | 12.13M |
September 30, 2023 | 12.55M |
June 30, 2023 | 12.32M |
March 31, 2023 | 18.75M |
December 31, 2022 | 19.41M |
September 30, 2022 | 24.19M |
June 30, 2022 | 24.36M |
March 31, 2022 | 6.360M |
December 31, 2021 | 7.956M |
September 30, 2021 | 8.010M |
June 30, 2021 | 8.913M |
March 31, 2021 | 9.951M |
December 31, 2020 | 11.77M |
September 30, 2020 | 14.89M |
June 30, 2020 | 15.80M |
March 31, 2020 | 15.11M |
December 31, 2019 | 16.90M |
September 30, 2019 | 4.800M |
June 30, 2019 | 5.616M |
March 31, 2019 | -0.783M |
December 31, 2018 | -0.362M |
September 30, 2018 | 0.058M |
June 30, 2018 | 0.538M |
March 31, 2018 | -1.087M |
Date | Value |
---|---|
December 31, 2017 | -0.477M |
September 30, 2017 | 1.764M |
June 30, 2017 | 5.104M |
March 31, 2017 | 8.782M |
December 31, 2016 | 12.50M |
September 30, 2016 | 15.78M |
June 30, 2016 | 18.81M |
March 31, 2016 | 22.22M |
December 31, 2015 | 25.35M |
September 30, 2015 | 29.04M |
June 30, 2015 | 32.47M |
March 31, 2015 | 35.53M |
December 31, 2014 | 29.00M |
September 30, 2014 | 31.58M |
June 30, 2014 | 34.90M |
March 31, 2014 | 23.85M |
December 31, 2013 | 6.043M |
September 30, 2013 | 7.706M |
June 30, 2013 | 7.414M |
March 31, 2013 | 4.349M |
December 31, 2012 | 4.546M |
September 30, 2012 | 5.616M |
June 30, 2012 | 6.118M |
March 31, 2012 | 7.513M |
December 31, 2011 | 8.797M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.800M
Minimum
Sep 2019
24.36M
Maximum
Jun 2022
13.08M
Average
12.22M
Median
Shareholders Equity (Quarterly) Benchmarks
Mosaic ImmunoEngineering Inc | -5.871M |
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 29.97M |
Total Liabilities (Quarterly) | 18.72M |